Health Economics

1992 - 2025

Current editor(s): Alan Maynard, John Hutton and Andrew Jones

From John Wiley & Sons, Ltd.
Bibliographic data for series maintained by Wiley Content Delivery ().

Access Statistics for this journal.
Is something missing from the series or not right? See the RePEc data check for the archive and series.

Volume 11, issue 8, 2002

Why health equity? pp. 659-666

Amartya Sen

Reducing avoidable inequalities in health: a new criterion for setting health care capitation payments pp. 667-677

Katharina Hauck, Rebecca Shaw and Peter C. Smith

QALY‐maximisation and public preferences: results from a general population survey pp. 679-693

Stirling Bryan, Tracy Roberts, Chris Heginbotham and Alison McCallum

A theoretical model of adolescent suicide and some evidence from US data pp. 695-708

Vijay K. Mathur and Donald G. Freeman

The subjective costs of health losses due to chronic diseases. An alternative model for monetary appraisal pp. 709-722

Ada Ferrer‐i‐Carbonell and Bernard van Praag

The importance of being first: evidence from Canadian generic pharmaceuticals pp. 723-734

Aidan Hollis

Cost data for individual patients included in clinical studies: no amount of statistical analysis can compensate for inadequate costing methods pp. 735-739

Nicholas Graves, Damian Walker, Rosalind Raine, Andrew Hutchings and Jennifer A. Roberts

Volume 11, issue 7, 2002

Do competition and managed care improve quality? pp. 571-584

Nazmi Sari

Revealed preference valuation compared to contingent valuation: radon‐induced lung cancer prevention pp. 585-598

Christine A. Kennedy

A comparison of consensus and nonconsensus approaches to modeling contraceptive choice behavior pp. 599-622

Li‐Wei Chao

Willingness to pay for health risk reduction in the context of altruism pp. 623-635

Jorge Araña and Carmelo J. León

Superbugs II: how should economic evaluation be conducted for interventions which aim to contain antimicrobial resistance? pp. 637-647

Joanna Coast, Richard Smith, Anne‐Marie Karcher, Paula Wilton and Michael Millar

Recognising diversity in public preferences: the use of preference sub‐groups in cost‐effectiveness analysis. A response to Sculpher and Gafni pp. 649-651

Angela Robinson and David Parkin

Recognising diversity in public preferences: the use of preference sub‐groups in cost‐effectiveness analysis. Authors' reply pp. 653-654

Mark Sculpher and Amiram Gafni

Decision making heuristics and the elicitation of preferences: being fast and frugal about the future pp. 655-658

John Cairns, Marjon van der Pol and Andrew Lloyd

Volume 11, issue 6, 2002

Guest Editors' Introduction pp. 469-470

Andrew Jones and Owen O'Donnell

Disentangling the effects of morbidity and life expectancy on labor market outcomes pp. 471-483

M. Christopher Auld

Rational addiction to alcohol: panel data analysis of liquor consumption pp. 485-491

Badi Baltagi and James M. Griffin

Keeping nurses at work: a duration analysis pp. 493-503

Tor Helge Holmås

An econometric analysis of the mental‐health effects of major events in the life of older individuals pp. 505-520

Maarten Lindeboom, France Portrait and Gerard van den Berg

How important are tobacco prices in the propensity to start and quit smoking? An analysis of smoking histories from the Spanish National Health Survey pp. 521-535

Ángel López Nicolás

Vertical and horizontal aspects of socio‐economic inequity in general practitioner contacts in Scotland pp. 537-549

Matthew Sutton

Bayesian estimation, simulation and uncertainty analysis: the cost‐effectiveness of ganciclovir prophylaxis in liver transplantation pp. 551-566

David Vanness and W. Ray Kim

The Purchasing of Health Care by Primary Care Organisations. An evaluation and Guide to Future Policy, by N. Mays, S. Wyke, G. Malbon, N. Goodwin. Open University Press, Buckingham and Philadelphia, 2001. No. of pages: 320. ISBN 0‐335‐20900‐9 pp. 567-568

Nancy Devlin

Volume 11, issue 5, 2002

Does prospective payment reduce inpatient length of stay? pp. 377-387

Edward Norton, Courtney Van Houtven, Richard Lindrooth, Sharon‐Lise T. Normand and Barbara Dickey

The benefits of switching smoking cessation drugs to over‐the‐counter status pp. 389-402

Theodore E. Keeler, Teh‐wei Hu, Alison Keith, Richard Manning, Martin D. Marciniak, Michael Ong and Hai‐Yen Sung

The impact of diabetes on adult employment and earnings of Mexican Americans: Findings from a community based study pp. 403-413

Elena Bastida and José A. Pagán

Something old, something new, something borrowed, something blue: a framework for the marriage of health econometrics and cost‐effectiveness analysis pp. 415-430

Jeffrey Hoch, Andrew H. Briggs and Andrew R. Willan

Social risk management options for medical care in Indonesia pp. 431-446

Menno Pradhan and Nicholas Prescott

A new explanation for the difference between time trade‐off utilities and standard gamble utilities pp. 447-456

Han Bleichrodt

Using stated preference discrete choice modelling to evaluate the introduction of varicella vaccination pp. 457-465

Jane Hall, Patricia Kenny, Madeleine King, Jordan Louviere, Rosalie Viney and Angela Yeoh

Health economics resources ‐ an update pp. 467-468

Bruce Hollingsworth

Volume 11, issue 4, 2002

Prenatal screening for cystic fibrosis: an economic analysis pp. 285-299

Randi Nielsen and Dorte Gyrd‐Hansen

Latent class versus two‐part models in the demand for physician services across the European Union pp. 301-321

Sergi Jiménez‐Martín, Jose Labeaga and Maite Martínez‐Granado

Do Medicare HMOs still reduce health services use after controlling for selection bias? pp. 323-340

Michelle M. Mello, Sally Stearns and Edward Norton

Estimating an EQ‐5D population value set: the case of Japan pp. 341-353

Aki Tsuchiya, Shunya Ikeda, Naoki Ikegami, Shuzo Nishimura, Ikuro Sakai, Takashi Fukuda, Chisato Hamashima, Akinori Hisashige and Makoto Tamura

Discounting and clinical decision making: Physicians, patients, the general public, and the management of asymptomatic abdominal aortic aneurysms pp. 355-370

S. Höjgård, U. Enemark, Carl Hampus Lyttkens, A. Lindgren, T. Troëng and H. Weibull

Unit root properties of OECD health care expenditure and GDP data pp. 371-376

Garry MacDonald and Sandra Hopkins

Volume 11, issue 3, 2002

On being NICE in the UK: guidelines for technology appraisal for the NHS in England and Wales pp. 185-191

Stephen Birch and Amiram Gafni

Neonatal health care costs related to smoking during pregnancy pp. 193-206

E. Kathleen Adams, Vincent P. Miller, Carla Ernst, Brenda K. Nishimura, Cathy Melvin and Robert Merritt

On the empirical association between poor health and low socioeconomic status at old age pp. 207-220

Christian Salas

A general model of the impact of absenteeism on employers and employees pp. 221-231

Mark V. Pauly, Sean Nicholson, Judy Xu, Dan Polsky, Patricia Danzon, James F. Murray and Marc L. Berger

Estimating survival gain for economic evaluations with survival time as principal endpoint: A cost‐effectiveness analysis of adding early hormonal therapy to radiotherapy in patients with locally advanced prostate cancer pp. 233-248

N. Neymark, I. Adriaenssen, T. Gorlia, S. Caleo and M. Bolla

Statistical determination of cost‐effectiveness frontier based on net health benefits pp. 249-264

Eugene M. Laska, Morris Meisner, Carole Siegel and Joseph Wanderling

Morality and the limits of societal values in health care allocation pp. 265-273

Rebecca L. Walker and Andrew W. Siegel

The familywise error rate of a simultaneous confidence band for the incremental net health benefit pp. 275-280

Morris Meisner, Eugene M. Laska, Carole Siegel and Joseph Wanderling

The European Union and Health Policy, by Ed Randall. Palgrave, Hampshire and New York, 2001. No. of pages: xiii+278. ISBN 0‐333‐75426‐3.. The Implications of Recent Jurisprudence on the Co‐ordination of Health Care Protection Systems, by Willy Palm, Jason Nickless, Henri Lewalle and Alain Coheur. Association Internationale de la Mutualite, Brussess, 2000. No. of pages: 170. [http://europa.eu.int/comm/employment_social/soc‐prot/disable/report.pdf]. Health Care Without Frontiers? The Development of a European Market in Health Services by Lyndsay Mountford. Office of Health Econ‐omics, London, 2000. No. of pages: 83. ISBN 1‐899040‐71‐4 pp. 281-284

Elias Mossialos

Volume 11, issue 2, 2002

The World Health Report 2000: dialogue of the deaf? pp. 93-101

Kjeld Møller Pedersen

Reflections on and alternatives to WHO's fairness of financial contribution index pp. 103-115

Adam Wagstaff

Testing the convergent validity of the contingent valuation and travel cost methods in valuing the benefits of health care pp. 117-127

Philip M. Clarke

Measuring willingness‐to‐pay for risk reduction: an application of conjoint analysis pp. 129-139

Harry Telser and Peter Zweifel

Socio‐economic health inequalities in Brazil: gender and age effects pp. 141-154

Maria Dolores Diaz

Obtaining disability weights in rural Burkina Faso using a culturally adapted visual analogue scale pp. 155-163

R.M.P.M. Baltussen, M. Sanon, J. Sommerfeld and R. Würthwein

How profitable is risk selection? A comparison of four risk adjustment models pp. 165-174

Yujing Shen and Randall Ellis

Is there a kink in consumers' threshold value for cost‐effectiveness in health care? pp. 175-180

Bernie J. O'Brien, Kirsten Gertsen, Andrew R. Willan and A. Faulkner

Health Economics for Developing Countries. A Practical Guide, by S. Witter, T. Ensor, M. Jowett and R. Thompson. MacMillan Education, London, 2000. No. of pages: 296. ISBN 0‐333‐75205‐8 pp. 181-181

Stephen Jan

User Fees for Health Services: Guidelines for Protecting the Poor, by William Newbrander, David Collins and Lucy Gilson. Management Sciences for Health, Boston, 2001. No. of pages: 74. ISBN 0‐913‐723‐80‐0.. Ensuring Equal Access to Health Services: User fee Systems and the Poor, by William Newbrander, David Collins and Lucy Gilson. Management Sciences for Health, Boston, 2001. No. of pages: 200. ISBN 0‐913‐723‐79‐7 pp. 182-182

Sophie Witter

Volume 11, issue 1, 2002

Decision validity should determine whether a generic or condition‐specific HRQOL measure is used in health care decisions pp. 1-8

Jack Dowie

Commentary on Jack Dowie, “Decision validity should determine whether a generic or condition‐specific HRQOL measure is used in health care decisions” pp. 9-12

Gordon Guyatt

Commentary on Jack Dowie, “Decision validity should determine whether a generic or condition‐specific HRQOL measure is used in health care decisions” pp. 13-16

David Feeny

Measures of health‐related quality of life in an imperfect world: a comment on Dowie pp. 17-19

John Brazier and Ray Fitzpatrick

‘Decision validity…’: A rejoinder pp. 21-22

Jack Dowie

Opportunity costs and uncertainty in the economic evaluation of health care interventions pp. 23-31

P. Sendi, A. Gafni and S. Birch

Estimation of the transition matrix of a discrete‐time Markov chain pp. 33-42

Bruce A. Craig and Peter P. Sendi

Measuring the social importance of concentration or dispersion of individual health benefits pp. 43-53

Eva Rodríguez‐Míguez and José‐Luis Pinto‐Prades

The distribution problem in economic evaluation: income and the valuation of costs and consequences of health care programmes pp. 55-70

Cam Donaldson, Stephen Birch and Amiram Gafni

The practicality and validity of directly elicited and SF‐36 derived health state preferences in patients with low back pain pp. 71-85

William Hollingworth, Richard A. Deyo, Sean D. Sullivan, Scott S. Emerson, Darryl T. Gray and Jeffrey G. Jarvik

Health economics: an evolving paradigm but sailing in the wrong direction? A view from the front line pp. 87-88

David Kernick